A. Helgason et al., WANING SEXUAL FUNCTION - THE MOST IMPORTANT DISEASE-SPECIFIC DISTRESSFOR PATIENTS WITH PROSTATE-CANCER, British Journal of Cancer, 73(11), 1996, pp. 1417-1421
The objective was to investigate how prostate cancer and its treatment
affects sexual, urinary and bowel functions and to what extent eventu
al complications cause distress. A questionnaire was sent to 431 men a
ged 50-80 years with prostate cancer diagnosed in 1999 in the Stockhol
m area (Sweden) and 435 randomly selected men with a similar age distr
ibution. Sexual function, as compared with their youth, was diminished
in a majority of all men. The prostate cancer patients were, however,
more likely to report low frequency and/or intensity in all aspects o
f sexual function. A majority of the men were distressed by a waning s
exual capacity. The proportion of men with prostate cancer who were se
verely distressed owing to a decline in sexual function was larger tha
n in the reference group. The willingness to trade off an intact sexua
l function for long-term survival varied considerably among the men in
the reference group. Urinary and bowel symptoms were less common than
a waning sexual function in both groups, and few appeared to be sever
ely distressed by urinary or bowel symptoms. A decline in sexual funct
ions was the most common cause of disease-specific distress in men wit
h prostate cancer.